These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3545974)

  • 1. [Immunodeficiency in lymphoproliferative processes and possibilities of correcting it].
    Kirzon SS; Vlasov AA; Snisar' NA; Cheredeev AN; Arion VIa
    Gematol Transfuziol; 1987 Jan; 32(1):18-24. PubMed ID: 3545974
    [No Abstract]   [Full Text] [Related]  

  • 2. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa; Ivanushkin EF
    Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic and clinical indicators in patients with lymphocytic leukemia after administration of T-activin].
    Lebedev VN; Markova TP; Lebedeva IuL; Ushakova ON
    Gematol Transfuziol; 1987 Jun; 32(6):30-4. PubMed ID: 3623055
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary immunodeficiency and its correction with thymus preparations in patients with postabortion endometritis].
    Franchuk AE; Benzar ZT
    Akush Ginekol (Mosk); 1990 Sep; (9):40-3. PubMed ID: 2278306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Simultaneous occurrence of Sézary syndrome and B-cell chronic lymphocytic leukaemia].
    Parisi E; Clody P; Mazurier I; Grange F; Tortel MC; Moskovtchenko P
    Ann Biol Clin (Paris); 2003; 61(1):94-8. PubMed ID: 12604393
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
    Arion VIa; Bekman EM; Tiurin NA; Mazurina NA; Filimonova AV
    Biull Eksp Biol Med; 1994 Nov; 118(11):496-8. PubMed ID: 7888649
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of treatment with the preparation TFX "Polfa" of 4 patients with acquired immunologic deficiency syndromes].
    Romański B; Montowska L; Zbikowska-Götz M; Staszyńska M
    Pol Tyg Lek; 1985 Oct 7-14; 40(40-41):1139-42. PubMed ID: 3911181
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of taktivin in experimental apical periodontitis exacerbated by a secondary immunodeficiency state].
    Zyrianov GV; Dmitrieva LA; Frolova TM; Belopol'skiĭ AA; Babaian SS
    Stomatologiia (Mosk); 1993; 72(2):10-3. PubMed ID: 8048117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The results of treating patients with endogenous bronchial asthma with TFX].
    Moniuszko T; Szymański W; Chyrek-Borowska S
    Pol Tyg Lek; 1988 Jan 18-25; 43(3-4):111-3. PubMed ID: 3387316
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of immunoregulation using the TFX Polfa preparation in non-Hodgkin's lymphoma].
    Górski J; Kicińska M; Gawrecka G
    Przegl Lek; 1988; 45(7):555-8. PubMed ID: 3070639
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Thymosin therapy creates a "Hassall"(?).
    Hong R; Horowitz S
    N Engl J Med; 1975 Jan; 292(2):104-5. PubMed ID: 1078550
    [No Abstract]   [Full Text] [Related]  

  • 12. A trial of immunologic stimulation with thymic extract (TFX) in untreated chronic lymphocytic leukemia.
    Wazewska-Czyzewska M; Aleksandrowicz J; Turowski G; Blicharski J; Dobrowolski J; Dolezalowa M
    Acta Med Pol; 1976; 17(2):97-110. PubMed ID: 937067
    [No Abstract]   [Full Text] [Related]  

  • 13. Sézary syndrome coexisting with B-cell chronic lymphocytic leukemia: case report and review of the literature.
    Karsai S; Hou JS; Telang G; Kantor GR; Nowell PC; Vonderheid EC
    Dermatology; 2008; 216(1):68-75. PubMed ID: 18032903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of thymosin in the treatment of primary immunodeficiency diseases and cancer.
    Goldstein AL; Cohen GH; Rossio JL; Thurman GB; Brown CN; Ulrich JT
    Med Clin North Am; 1976 May; 60(3):591-606. PubMed ID: 131889
    [No Abstract]   [Full Text] [Related]  

  • 15. Which thymic hormone?
    Lancet; 1983 Jun; 1(8337):1309-11. PubMed ID: 6134098
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
    Mel'nik VP
    Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-immunologic effect of tactivin in chronic myeloid leukemia].
    Abdulkadyrov KM; Guseva SA
    Gematol Transfuziol; 1994; 39(5):19-22. PubMed ID: 7896024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypogammaglobulinemia and immunodeficiency in multiple myeloma and chronic lymphoid leukemia].
    Matthes T; Jandus P
    Rev Med Suisse; 2023 Apr; 19(821):668-673. PubMed ID: 37017348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological activity and physico-chemical properties of TFK thymic extract].
    Skotnicki AB
    Pol Tyg Lek; 1978 Jul; 33(28):1119-22. PubMed ID: 704411
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymic hormone dependent immunodeficiency in an infant with partial trisomy of chromosome 22.
    Tovo PA; Davi G; Fraceschini P; Delpiano A
    Thymus; 1986; 8(5):313-8. PubMed ID: 3798528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.